BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36216763)

  • 21. Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases.
    Zhou L; Xu J; Wang S; Yang X; Li C; Zhou J; Zhang P; Xu H; Wang C
    Int J Surg Pathol; 2020 Oct; 28(7):728-734. PubMed ID: 32403965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary renal neoplasm with reverse polarity: A case report.
    Xing C; Tian H; Zhang Y; Zhang L; Kong J
    Front Oncol; 2023; 13():1072213. PubMed ID: 37143937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity.
    Al-Obaidy KI; Eble JN; Nassiri M; Cheng L; Eldomery MK; Williamson SR; Sakr WA; Gupta N; Hassan O; Idrees MT; Grignon DJ
    Mod Pathol; 2020 Jun; 33(6):1157-1164. PubMed ID: 31534204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study.
    Al-Obaidy KI; Eble JN; Cheng L; Williamson SR; Sakr WA; Gupta N; Idrees MT; Grignon DJ
    Am J Surg Pathol; 2019 Aug; 43(8):1099-1111. PubMed ID: 31135486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
    Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
    Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metachronous bladder metastases of a type 2 papillary renal cell carcinoma: a case report and review of the literature.
    Gajasinghe DG; Nazeer I; Maddumage HP; Perera C; Abeygunasekera AM
    World J Surg Oncol; 2016 Aug; 14(1):219. PubMed ID: 27549183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal cell carcinoma with (tubule) papillary architecture. Report of three cases and bibliographic review.].
    Jalón-Monzón A; Santos-Juares J; Hevia-Suárez MA; Álvarez-Múgica M; Escaf-Barmadah S
    Arch Esp Urol; 2019 Jun; 72(5):535-539. PubMed ID: 31223132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
    Diolombi ML; Cheng L; Argani P; Epstein JI
    Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases.
    McKenney JK; Amin MB; Young RH
    Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?
    Hes O; Condom Mundo E; Peckova K; Lopez JI; Martinek P; Vanecek T; Falconieri G; Agaimy A; Davidson W; Petersson F; Bulimbasic S; Damjanov I; Jimeno M; Ulamec M; Podhola M; Sperga M; Pane Foix M; Shelekhova K; Kalusova K; Hora M; Rotterova P; Daum O; Pivovarcikova K; Michal M
    Am J Surg Pathol; 2016 May; 40(5):664-75. PubMed ID: 26999503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cáncer renal papilar tipo 2, asociado a piloleiomiomatosis y tumor testicular bilateral de células de Leydig.
    Cortés-Vázquez YD; Cortés-Vázquez AR; Sánchez-Coral MA; Priego-Niño A; Mercado-Vargas RZ; Castillo-Canto CO
    Cir Cir; 2020; 88(Suppl 2):94-98. PubMed ID: 33284259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases.
    Toll AD; Epstein JI
    Am J Surg Pathol; 2012 Jul; 36(7):1081-6. PubMed ID: 22510761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Large nested variant of urothelial carcinoma of urinary bladder: a clinicopathological analysis of five cases].
    Yin XN; Zhang Q; He XL; Zhao M
    Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):317-323. PubMed ID: 32268667
    [No Abstract]   [Full Text] [Related]  

  • 39. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
    Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A
    BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The radiologist's role in the management of papillary renal cell carcinoma.
    Corral de la Calle MÁ; Encinas de la Iglesia J; Martín López MR; Fernández Pérez GC; Águeda Del Bas DS
    Radiologia; 2017; 59(2):100-114. PubMed ID: 28160948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.